Advertisements


Shire sells cancer drugs to Servier for $2.4B as Takeda circles

Shire said on Monday it would consider returning proceeds from the sale to shareholders through a buyback and that further selective disposals of non-strategic assets were possible......»»

Category: topSource: foxnewsApr 16th, 2018

Shire sells cancer drugs to Servier as Takeda circles

Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceu.....»»

Category: videoSource: reutersApr 16th, 2018

Shire sells cancer drugs to Servier for $2.4B as Takeda circles

Shire said on Monday it would consider returning proceeds from the sale to shareholders through a buyback and that further selective disposals of non-strategic assets were possible......»»

Category: topSource: foxnewsApr 16th, 2018

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

LONDON (Reuters) - Shire , the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical , is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion......»»

Category: topSource: reutersApr 16th, 2018

Shire Sells Oncology Unit Ahead of Takeda"s Potential Offer

Shire (SHPG) sells its oncology segment to France-based Servier for $2.4 billion. T.....»»

Category: smallbizSource: nytApr 17th, 2018

Japan"s Takeda sweetens $62 billion Shire offer

TOKYO/LONDON (Reuters) - Japan's Takeda Pharmaceutical nudged up its offer for Shire to 44.3 billion pounds ($62 billion) on Friday to try to persuade the rare-disease drugs specialist into talks after it rejected three previous proposals......»»

Category: topSource: reutersApr 20th, 2018

Shire to Sell Oncology Unit as Takeda Mulls Takeover

Shire has agreed to sell its oncology business to French drugmaker Servier for $2.4 billion, in a deal that could discourage Takeda from launching a takeover......»»

Category: smallbizSource: wsjApr 16th, 2018

Shire to Sell Oncology Unit for $2.4 Billion as Takeda Mulls Takeover

Shire has agreed to sell its oncology business to French drugmaker Servier for $2.4 billion, in a deal that could discourage Takeda from launching a takeover......»»

Category: smallbizSource: wsjApr 16th, 2018

Cambridge biotech Enumeral files for bankruptcy, sells cancer drugs

The nine-year-old company generated some buzz in 2014 by signing a partnership deal with Merck, but never tested its experimental treatments in a human trial......»»

Category: topSource: bizjournalsFeb 6th, 2018

Takeda has reached a breakthrough in its talks to buy Shire (SHPG)

Thomson Reuters Shire and Takeda are announc.....»»

Category: topSource: businessinsider5 hr. 1 min. ago

Exclusive: Shire, Takeda reach breakthrough in deal talks - sources

(Reuters) - London-listed drugmaker Shire Plc and Japan's Takeda Pharmaceutical Co Ltd plan to announce a preliminary deal on Wednesday, after the latter sweetened its $62 billion acquisition offer, people familiar with the matter said......»»

Category: topSource: reuters5 hr. 47 min. ago

Takeda Makes Last-Gasp Move for Rival Drugmaker Shire

Takeda made a fifth takeover proposal for rival drugmaker Shire, a last-ditch move by the Japanese company that would likely value the rare-drug specialist at more than $60 billion......»»

Category: smallbizSource: wsj9 hr. 47 min. ago

Shire rises 6.1% after report of improved takeover bid from Takeda

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatch15 hr. 46 min. ago

If Takeda Walks Then Shire Could Crater

If Takeda Walks Then Shire Could Crater.....»»

Category: topSource: seekingalpha19 hr. 16 min. ago

Takeda Can’t Afford to Kick Its $60 Billion Shire Habit: Gadfly

Takeda Can’t Afford to Kick Its $60 Billion Shire Habit: Gadfly.....»»

Category: topSource: washpostApr 23rd, 2018

Shire’s Tug of War

A closer look at the recent developments at Shire Plc, including the sale of its oncology business, label expansion of Vonvendi and the buyout bids from Allergan and Takeda PharmaceuticalsRelated Stocks: SHPGF, TKPHF, AGN,.....»»

Category: personnelSource: nytApr 23rd, 2018

Shire (SHPG) Turns Down Takeda"s Third Buyout Proposition

Shire (SHPG) declines Takeda Pharmaceutical's third acquisition offer in a cash-stock d.....»»

Category: smallbizSource: nytApr 20th, 2018

Takeda sweetens $60 billion Shire pitch as rival bows out

Japanese pharmaceutical company Takeda took a fourth try at buying Shire on Friday, less than 24 hours after a potential rival bidder ruled itself out of a tug-of-war for the biotech firm......»»

Category: topSource: cnnApr 20th, 2018

Shire spikes up 1.6% after commenting on latest Takeda proposal

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 20th, 2018

Shire "considering position" on latest proposal from Takeda

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 20th, 2018

Takeda Sweetens Takeover Proposal for Shire

Japan’s Takeda said it had made a sweetened proposal to buy Shire after its three previous bids for the rival drugmaker that has drawn broader interest across the sector were rejected......»»

Category: smallbizSource: wsjApr 20th, 2018